The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global body composition analyzers market reached a value of US$ 545 Million in 2020. Looking forward, IMARC Group expects the market to grow at a CAGR of 9.4% during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
A body composition analyzer (BCA) is an equipment that is used to measure weight, body fat, water percentage, BMR, DCI, metabolic age, bone mass, muscle mass, and physique and visceral fat rating. It defines weight more accurately than body mass index (BMI) and is also capable of projecting cumulative variations in the body for a certain amount of time. Nowadays, a wide range of BCA models, including Ironman, FitScan and Innerscan, are available in the market that provide relevant measurement values and data to medical professionals, which helps in tracking patient progress, and the diagnostics and screening of obesity and associated comorbidities.
The primary factor bolstering the growth of the global BCA market is the rapid growth of the obese population due to sedentary lifestyles and unhealthy dietary patterns. With the rising obesity rates and other metabolic disorders, there has been an increase in awareness among individuals about the importance of health and wellness. This has encouraged them to join health clubs and fitness centers to reduce weight. As these centers utilize BCA to test the body composition of individuals regularly, it is providing a positive impact on the industry growth. Moreover, market players have also developed Bio-electrical Impedance Analysis (BIA), which is a non-invasive tool used by medical practitioners to measure the percentage of body fat. They have also developed ANT+ and Bluetooth wireless body composition analyzers with dual LCD units. Apart from this, due to the ongoing spread of coronavirus disease (COVID-19) across the globe, governments of various nations are making investments in the development of healthcare infrastructure, which is further creating a huge demand for medical devices.
IMARC Group provides an analysis of the key trends in each sub-segment of the global body composition analyzers market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on product and end user.
Breakup by Product:
Breakup by End User:
Breakup by Region:
The report has also analysed the competitive landscape of the market with some of the key players being Bodystat Ltd., COSMED Srl, GE Healthcare, Hologic Inc., Inbody Co. Ltd., Omron Corporation, RJL Systems Inc., Seca GmbH & Co. Kg., SELVAS Healthcare and Tanita Corporation.
|Base Year of the Analysis||2020|
|Segment Coverage||Product, End User, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Bodystat Ltd., COSMED Srl, GE Healthcare, Hologic Inc., Inbody Co. Ltd., Omron Corporation, RJL Systems Inc., Seca GmbH & Co. Kg., SELVAS Healthcare and Tanita Corporation|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2299
Five User License: US$ 3399
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at